Samsung to Set Up Biopharmaceutical Joint Venture

Reuters
Feb 24, 2011

Samsung Group, South Korea's largest conglomerate, said on Friday it planned to set up a biopharmaceutical joint venture with initial capital of 300 billion won ($264.4 million).
To read more click here...